强生(JNJ.US)Q3盈利超预期并上调全年业绩指引!创新药业务放量 器械业务仍待改善

智通财经
Yesterday
【强生(JNJ.US)Q3盈利超预期并上调全年业绩指引!创新药业务放量 器械业务仍待改善】智通财经APP获悉,周二美股盘前,强生(JNJ.US)公布了好于预期的2026年第三季度业绩,并上调2026全年收入与盈利指引。财报显示,强生第三季度销售额同比增长5.9%至254亿美元,符合市场普遍预期。盈利方面,在GAAP口径下的净利润同比骤降95.9%至2.10亿美元,摊薄后每股收益仅为0.09美元(上年同期为2.12美元),主因计入55.19亿美元滑石粉诉讼拟议解决方案相关一次性税前费用。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10